Eric D. Donnenfeld, MD; underscores the significance of an FDA approved treatment for Demodex blepharitis as well as past alternative treatments. This is a video synopsis/summary of an Insights ...

Shares in Grand Pharma tumbled today despite the Chinese drugmaker being given the greenlight to take its first-in-class eye ...

AJMC ®: In your opinion, why are there no formal guidelines for Demodex blepharitis? MATOSSIAN: Ophthalmologists and other eye care providers have known about Demodex blepharitis for a very long time.

Please provide your email address to receive an email when new articles are posted on . Demodex blepharitis is so common that it makes up more than two thirds of all blepharitis cases. In fact, nearly ...

Blepharitis, a chronic condition that causes inflammation of the eyelids, affects millions of people across the United States. Despite being common, it is frequently underdiagnosed or mistaken for ...